| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average Target Price on JOHNSON & JOHNSON |
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
AstraZeneca runs into 'meaningful' investor revolt over pay |
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
21 |
| Average target price |
183,67 $ |
| Last Close Price |
161,98 $ |
| Spread / Highest target |
25,9% |
| Spread / Average Target |
13,4% |
| Spread / Lowest Target |
-2,46% |
Consensus revision (last 18 months)
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
